Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
symbicort turbuhaler 9 mcg/doza + 320 mcg/doza prašak za inhalaciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol, budesonid - prašak za inhalaciju - 9 mcg/doza + 320 mcg/doza
Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
pulmicort 0.25mg/ml suspenzija za raspršivanje
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - budesonid - suspenzija za raspršivanje - 0.25mg/ml
Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
pulmicort 0.5mg/ml suspenzija za raspršivanje
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - budesonid - suspenzija za raspršivanje - 0.5mg/ml
Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
oxisturbuhaler 9.0 mcg/doza prašak za inhalaciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol - prašak za inhalaciju - 9.0 mcg/doza
Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
oxisturbuhaler 4.5 mcg/doza prašak za inhalaciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol - prašak za inhalaciju - 4.5 mcg/doza
Croatia -
Croatian -
HALMED (Agencija za lijekove i medicinske proizvode)
octagam 50 mg/ml otopina za infuziju
jana pharm d.o.o., lopašićeva 6, zagreb, hrvatska - imunoglobulin normalni, ljudski, intravenski - otopina za infuziju - 50 mg/ml - urbroj: jedan ml otopine za infuziju sadrži 50 mg imunoglobulina normalnog, ljudskog, što odgovara ukupnom sadržaju proteina od čega je najmanje 95% ljudski imunoglobulin g
European Union -
Croatian -
EMA (European Medicines Agency)
lumoxiti
astrazeneca ab - moxetumomab pasudotox - leukemije, dlakave stanice - antineoplastična sredstva - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).
European Union -
Croatian -
EMA (European Medicines Agency)
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multipli mijelom - antineoplastična sredstva - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
European Union -
Croatian -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - imuni serumi i homologna, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
Montenegro -
Croatian -
CInMED-Institut za ljekove i medicinska sredstva Crne Gore
pregnyl 5000i.j. prašak i rastvarač za rastvor za injekciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - horionski gonadotropin - prašak i rastvarač za rastvor za injekciju - 5000i.j.